Rhabdoid tumor predisposition syndrome: A historical review of treatments and outcomes for associated pediatric malignancies
Pediatric Blood & Cancer · 2024-06 · 71 (6)
DOI: 10.1002/pbc.30979 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 30.03.2024. Verfasst von Sarah Andres und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, Buffalo, New York, USA. Hauptthemen laut MEDLINE: Rhabdoid Tumor, Kidney Neoplasms, Teratoma. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Rhabdoid tumor predisposition syndrome (RTPS) is a rare disorder associated with malignant rhabdoid tumor of the kidney (RTK), atypical teratoid rhabdoid tumor (ATRT), and/or other extracranial, extrarenal rhabdoid tumors (EERT), and these pediatric malignancies are difficult to treat. Presently, most of the information regarding clinical manifestations, treatment, and outcomes of rhabdoid tumors comes from large data registries and case series. Our current understanding of treatments for patients with rhabdoid tumors may inform how we approach patients with RTPS. In this manuscript, we review the genetic and clinical features of RTPS and, using known registry data and clinical reports, review associated tumor types ATRT, RTK, and EERT, closing with potential new approaches to treatment. We propose collaborative international efforts to study the use of SMARC (SWI/SNF‐related, matrix‐associated, actin‐dependent regulator of chromatin)‐targeting agents, high‐dose consolidative therapy, and age‐based irradiation of disease sites in RTPS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, Buffalo, New York, USA.
- The Division of Hematology and Oncology, St. Louis Children's Hospital, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
- Division of Hematology/Oncology/Bone Marrow Transplant, Department of Pediatrics, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA.
- Departments of Pediatrics and Radiation Oncology, The Ohio State University College of Medicine, Columbus, Ohio, USA.
- Division of Pediatric Oncology, Department of Pediatrics, Roswell Park Comprehensive Cancer Center, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, USA.
ORCID-Profile: Mohamed S Abdelbaki, Jonathan Finlay, Ajay Gupta
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Andres, S., Huang, K., Shatara, M., Abdelbaki, M. S., Ranalli, M., Finlay, J., & Gupta, A. (2024). Rhabdoid tumor predisposition syndrome: A historical review of treatments and outcomes for associated pediatric malignancies. Pediatric Blood & Cancer, 71(6). https://doi.org/10.1002/pbc.30979
Vancouver
Andres S, Huang K, Shatara M, Abdelbaki MS, Ranalli M, Finlay J, et al. Rhabdoid tumor predisposition syndrome: A historical review of treatments and outcomes for associated pediatric malignancies. Pediatric Blood & Cancer. 2024;71(6). doi:10.1002/pbc.30979
BibTeX
@article{Andres2024,
author = {Andres, Sarah and Huang, Karen and Shatara, Margaret and Abdelbaki, Mohamed S and Ranalli, Mark and Finlay, Jonathan and Gupta, Ajay},
title = {Rhabdoid tumor predisposition syndrome: A historical review of treatments and outcomes for associated pediatric malignancies},
journal = {Pediatric Blood & Cancer},
year = {2024},
volume = {71},
number = {6},
doi = {10.1002/pbc.30979}
}
EUVIMED